ReviewCancers2018

Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer.

Babak Nami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.